对MACC1-AS1的全面见解:癌症中的作用和治疗影响
Chenhao Liang1, Yaojie Feng2, Yuhua Zhang1
1Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China; Department of Clinical Medicine, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China.
Gene
|September 30, 2025
概括
长非编码RNA的MACC1-AS1在许多癌症中过度表达,并与预后不佳有关. 它驱动癌症的进展和治疗耐药性,显示作为生物标志物和药物点的潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 癌症研究 癌症研究
背景情况:
- 长非编码RNAs (lncRNAs) 调节基因表达和疾病.
- MACC1-AS1,转录为MACC1的反意义,在十种癌症中过度表达,与预后不佳相关.
- MACC1-AS1由IFN-γ,PTBP1,Smad2,TGF-β1和Kras.等上游因素进行调节.
研究的目的:
- 审查有关MACC1-AS1.1.的当前知识.
- 突出MACC1-AS1在癌症进展和治疗耐药性的作用.
- 讨论MACC1-AS1作为生物标志物和治疗点的潜力.
主要方法:
- 关于MACC1-AS1.1.的文献审查
- 对MACC1-AS1的分子机制的分析.
- 检查MACC1-AS1在癌症信号通路中的参与.
主要成果:
- MACC1-AS1作为一个ceRNA,结合MACC1mRNA,并调节转录因子.
- 它影响了扩散,亡,EMT,入侵,迁移和癌症干.
- MACC1-AS1 赋予了对化学疗法如5-FU,氧化,凝,西斯和FOLFOX的耐药性.
结论:
- MACC1-AS1是多种癌症特征中的关键参与者.
- 它对治疗耐药性有显著的贡献.
- 在转化癌症研究中,MACC1-AS1是一个有前途的生物标志物和治疗标.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


